Public health, innovation and intellectual property 1 |

The Global Platform on

Innovation and Access

to medical products and technologies

EMP technical briefing seminar, Geneva 6 November 2014

Claudia Nannei

Public health, innovation and intellectual property 2 |

Global Strategy and Plan of Action on Public

Health, Innovation and Intellectual Property

Promote new thinking on innovation and access to medicines

and

Secure an enhanced and sustainable basis for needs-driven

essential health research and development relevant to diseases

that disproportionately affect developing countries.

Its aim:

Public health, innovation and intellectual property 3 |

Global Strategy and Plan of Action on Public

Health, Innovation and Intellectual Property

Set, prioritize and promote

research;

Foster and build innovation

capacity;

Promote technology transfer and

local production of medical products;

Improve access to medical

products;

How? Offering an holistic approach to the issue of innovation for

medical technologies to address diseases

disproportionally affecting developing countries and

proposing specific actions to:

Promote the management and

application of intellectual property rights

to improve public health;

Mobilize resources for research and

development relevant to this area and

Monitor and evaluate the progress in

all these areas.

Public health, innovation and intellectual property 4 |

How can national governments coordinate their

policies for the needed innovation to take place?

Innovation for health is a complex issue that requires multi-

sectorial approach and coordination

Innovation involves government policies and legislation in

public health, international trade, national and international

procurement, industrial development, finance, education,

science and technology, international relations and

cooperation

Public health, innovation and intellectual property 5 |

A simple mapping tool

National assessment tool for public health, innovation

and intellectual property (NAT):

– mapping health R&D policies, system, infrastructure, human

resources and financing; access to know how and technology

transfer, local production capacity for pharmaceuticals;

intellectual property management; regulation and procurement of

medical products and technologies, incentives for health

innovation, health delivery infrastructures, trade agreements,

information monitoring systems.

Public health, innovation and intellectual property 6 |

WHY?

Identify areas for improvement,

Identify contradictory policies,

Identify synergies

Create necessary coordination among agencies

=> ensure policy coherence

Public health, innovation and intellectual property 7 |

GSPA-PHI: the mandate

Element 8 Establishing monitoring and reporting systems

Member States to anda requires WHO 8.1 Specific action

Establish systems to monitor performance and progress of the

implementation of each element of the GSPA

Public health, innovation and intellectual property 8 |

Global Platform on

Innovation and Access

Public health, innovation and intellectual property 9 |

What is it?

New web-based platform for governments, intergovernmental organizations,

public health researchers, NGOs and other stakeholders

Provides user-friendly, reliable and regularly updated information on

innovation and access to medical products and technologies and GSPA-PHI

implementation

Unique point to store, access, analyse and share information collected

through the NAT;

Repository of relevant policies and legislations on the areas contributing to

innovation

Networking tool through its virtual forum on innovation

Public health, innovation and intellectual property 10 |

GPIA will ensure:

Better design and management of regional and national health research and innovation systems;

More efficient innovation based on combined expertise which has been traditionally working in isolation;

More effective and targeted capacity-building programs, tailored to identified national gaps and needs; and,

Creation of a visible and responsible global community working together to facilitate innovation for and access to medical products and technologies.

Expected outcomes

Policy

coherence

Public health, innovation and intellectual property 11 |

Its structure

Public health, innovation and intellectual property 12 |

The Platform : its functions

Promoting Innovation and Access through

Global Strategies

GPIA

Public health, innovation and intellectual property 13 |

Current data sources

Pharmaceutical Sector Country Profile (PCP)

Regional Platform on Access and Innovation for Health

Technologies

Public health, innovation and intellectual property 14 |

Planned data sources

Global Health R&D Observatory

New PCP

Other WHO databases (NRA indicators, GHO…)

External links (WIPO Re:Search?)

Public health, innovation and intellectual property 15 |

The Platform : the development process

1st version

Information hub

Validation phase

Feedback

Adjustments

Evolution

Beta version

Repository

Innovation forum

2, 3… nth

version

maintenance

Public health, innovation and intellectual property 16 |

THANK YOU!!!

And stay tuned for future developments!

Claudia Nannei

EMP/PHI

nanneic@who.int